Tag Archives: U.S. Food and Drug Administration

SMER28

Journal of Federation of American Societies for Experimental Biology March 7, 2011 Full PDF: Click Here Fisher Scientists Discover New Ways to Rid Cells of Alzheimer Protein Identifying a cure for Alzheimer’s disease remains a major challenge. Few drugs are … Continue reading

New Extended-Release Form of Namenda Is Approved

An extended-release form of Namenda, the drug used to treat moderate to severe Alzheimer’s disease, was approved by the US Food and Drug Administration. The approval clears the way for the drug to be sold in U.S. pharmacies. Namenda, also … Continue reading

What Drugs are Approved for Alzheimer’s Disease?

Five drugs have been approved by the U.S. Food and Drug Administration (FDA) for treating the cognitive symptoms of Alzheimer’s disease. Reminyl, Exelon, Aricept and Cognex belong to a class of drugs known as cholinesterase inhibitors. Each acts in a … Continue reading